MYND - マインド・アナリティックス （MYnd Analytics Inc.） マインド・アナリティックスMYNDのチャート
MYNDの企業情報
| symbol | MYND |
|---|---|
| 会社名 | MYnd Analytics Inc （マインド・アナリティックス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Hospital/Nursing Management |
| 業種 | ヘルスケア施設_サ―ビス 医療関連（Health Care） |
| 概要 | 事業概要 MYnd Analytics Inc. formerly CNS Response Inc. is a predictive analytics company. The Company has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide personalized care to patients. The Company provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders including depression anxiety bipolar disorder post-traumatic stress disorder (PTSD) and other non-psychotic disorders. The Company uses its neurometric platform PEER Online to generate Psychiatric electroencephalogram (EEG) Evaluation Registry (PEER) Reports to predict the likelihood of response by an individual to a range of medications prescribed for the treatment of behavioral disorders. As of September 30 2016 the PEER Online database comprises over 38 000 clinical outcomes for over 10 200 patients with psychiatric or addictive problems. マインド・アナリティックスは米国の医療サ―ビス企業。主に、うつ病、双極性障害、心的外傷後ストレス障害などを扱う精神医療提供者向けの医療サ―ビスを提供する。同社はニュ―ロメリック・プラットフォ―ム「PEER Online」を通じ、行動障害治療用の処方薬に対する患者の反応を予測するため、精神脳波記録を作成する。本社所在地はカリフォルニア州。 MYnd Analytics, Inc. operates as a predictive analytics company that has developed a decision support tool to help physicians reduce trial and error treatment in mental health and provide more personalized care to patients. It provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioural disorders, includes depression, anxiety, bipolar disorder, post-traumatic stress disorder, and other non-psychotic disorders. The company was founded by Leonard J. Brandt and Brain McDonald on March 20, 1987 and is headquartered in Aliso Viejo, CA. |
| 本社所在地 | 26522 La Alameda Suite 290 Mission Viejo CA 92691 USA |
| 代表者氏名 | George C. Carpenter ジョージC.カーペンター |
| 代表者役職名 | President Chief Executive Officer |
| 電話番号 | +1 949-420-4400 |
| 設立年月日 | 30864 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 18人 |
| url | www.myndanalytics.com |
| nasdaq_url | https://www.nasdaq.com/symbol/mynd |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -10.89220 |
| 終値（lastsale） | 1.38 |
| 時価総額（marketcap） | 9306105.9 |
| 時価総額 | 時価総額（百万ドル） 9.00637 |
| 売上高 | 売上高（百万ドル） 1.00760 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 6.94297 |
| 当期純利益 | 当期純利益（百万ドル） -10.60990 |
| 決算概要 | 決算概要 BRIEF: For the nine months ended 30 June 2018 MYnd Analytics Inc revenues increased from $95K to $974K. Net loss increased 78% to $8M. Revenues reflect Neurometric Services increase from $95K to $199K. Higher net loss reflects Interest expense net increase from $6K to $62K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$1.92 to -$1.48. |
MYNDのテクニカル分析
MYNDのニュース
Biocept and OncoSec Medical among healthcare gainers; Teva Pharmaceutical and Zynerba Pharmaceuticals among losers 2019/05/28 15:02:11 Seeking Alpha
Ekso Bionics and Tonix Pharmaceuticals among healthcare gainers; T2 Biosystems and Biocept among losers 2019/05/23 15:08:14 Seeking Alpha
MYnd Analytics Provides Business and Merger Updates 2019/05/13 13:15:00 Yahoo Finance
Merger with Emmaus on Track to Close Arcadian and PEER Online® Attracting Broad Support From Providers MISSION VIEJO, Calif., May 13, 2019 -- MYnd Analytics, Inc. (NASDAQ:.
Biocept and OncoSec Medical among healthcare gainers; Teva Pharmaceutical and Zynerba Pharmaceuticals among losers 2019/05/28 15:02:11 Seeking Alpha
Ekso Bionics and Tonix Pharmaceuticals among healthcare gainers; T2 Biosystems and Biocept among losers 2019/05/23 15:08:14 Seeking Alpha